ArticleiScience2026
Memory B cell response to SARS-CoV-2 vaccination in people with heart and lung transplantation: Identification of associated clinical factors.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Solid organ transplant recipients (SOT) have shown impaired immune responses to infection and vaccination. Here, serological data collected in heart and lung transplant recipients after vaccination against SARS-CoV-2 were analyzed using dimensionality reduction, clustering algorithms and statistical methods to define factors associated with immune responsiveness. Transplanted organ type, bivalent Omicron-adapted vaccine administration, and immunosuppressive regimen were associated with distinct serological profiles. These factors were associated with significant differences in the RBD-specific memory B cell (MBC) responses. Indeed, a lower frequency of MBC recognizing both wild-type and Omicron BA.2 RBD was detected in lung versus heart transplant recipients. Administration of the bivalent Omicron-adapted fifth dose was associated with the modulation of RBD-specific MBC phenotypes, and the mycophenolate mofetil (MMF) treatment was associated with significantly lower humoral and MBC responses in heart transplant recipients. This work identifies factors associated with vaccine-induced immune responses in SOT recipients, useful to inform tailored vaccination strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.